We simulated the evolution of resistance-acquisition to BETi in the two AML models that we had extensively tested so far: SKNO1 (RUNX1-RUNX1T1-rearranged) and OCI-AML3 (NPM1mut). This evidence concerns the gene RUNX1 and acute myeloid leukemia.